The present invention refers to new 5-(N-Alkyl-N-acylamino)-thiophen-2-carboxylic acid derivatives having the general formula I
process for producing the same and pharmaceutical compounds containing the same as active ingredient.
本发明是指具有通式 I 的新的 5-(N-烷基-N-酰
氨基)-
噻吩-2-
羧酸衍
生物,以及含有这些衍
生物作为活性成分的药物化合物。